[Indications of biologics, especially anti-TNF-alpha antibodies, for the treatment of psoriasis].
Nakagawa
Hidemi
H
Department of Dermatology, The Jikei University, School of Medicine. hidemi@jikei.ac.jp
D000068879:Adalimumab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002648:Child; D006801:Humans; D000069285:Infliximab; D011565:Psoriasis / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069285:Infliximab; D000068879:Adalimumab